Stevens Jennifer
Chief Regulatory Officer
Stevens Jennifer has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Oct 7, 2026.
On the most recent filing, Stevens Jennifer is listed as Chief Regulatory Officer at TriSalus Life Sciences, Inc. Inside the rolling window, Stevens Jennifer reported no open-market purchases and 4 open-market sales totaling $16K in TLSI. The largest disclosed transaction in the window is a sale of 1,552 TLSI shares on Mar 12, 2026, worth $6K.
Companies traded
Other insiders at TLSI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stevens Jennifer made?
Stevens Jennifer has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Stevens Jennifer trade?
Stevens Jennifer has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Stevens Jennifer's most recent SEC Form 4 filing?
Stevens Jennifer's most recent SEC Form 4 filing on Tracefour is dated Oct 7, 2026.
What is Stevens Jennifer's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Stevens Jennifer is listed as Chief Regulatory Officer.
What is Stevens Jennifer's total buy and sell value in the current window?
Inside the rolling retention window, Stevens Jennifer bought $0 and sold $16K based on SEC Form 4 filings.
What was Stevens Jennifer's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,552 TLSI shares on 2026-03-12, worth $6K, per SEC Form 4 filings.